UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
Clinicians and research staff from across England and Wales attended patient and public involvement training delivered by the BRC between April 2021 and March 2022.
A new artificial intelligence (AI) tool that can detect heart disease in record speed, helping to improve care for heart patients, is being rolled out at UCLH.
People without jobs or with less secure housing have poorer outcomes when treated for depression with talking therapy or antidepressants, compared to more socially advantaged peers, according to UCL led research.
A single DNA test has been developed that can screen a patient’s genome for over 50 genetic neurological and neuromuscular diseases such as Huntington’s disease, muscular dystrophies and fragile X syndrome.
Two UCL and UCLH studies will look at whether analysis of advanced MRI scans can predict onset of multiple sclerosis and indicate which MS patients are at risk of developing irreversible disability.
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
A collaboration between UCLH, UCL and industry to cut use of anaesthetic gases has been awarded £99,703 by SBRI Healthcare – an NHS funded programme to support an historic drive to deliver a net zero NHS.
